NCT02194244 Comparative Bioavailability Study of Film-coated Tablet and Granule Formulations of RG1662 Status COMPLETED Phase PHASE1
NCT02194166 A Study to Investigate the Tolerability of Subcutaneous (SC) Trastuzumab Administration in Participants With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Early Breast Cancer (eBC) Using Either a Single-Use Injection Device or Manual Administration Status COMPLETED Phase PHASE3
NCT02187861 A Study Evaluating the Safety and Efficacy of Venetoclax (GDC-0199) Plus Bendamustine + Rituximab (BR) in Comparison With BR or Venetoclax Plus Rituximab in Participants With Relapsed and Refractory Follicular Non-Hodgkin's Lymphoma (fNHL) Status COMPLETED Phase PHASE2
NCT02187627 Evaluation of [11C]RO6924963, [11C]RO6931643, and [18F]RO6958948 as Tracers for Positron Emission Tomography (PET) Imaging of Tau in Healthy and Alzheimer's Disease (AD) Participants Status COMPLETED Phase PHASE1
NCT02179866 A Single-center Study to Investigate How Quickly and to What Extent a Radioactive Dose of RO5285119 is Absorbed, Metabolized and Eliminated From the Body of Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT02178397 A Multicenter Randomized Phase III Study Comparing Second-line Treatment With Chemotherapy Associated or Not to Erlotinib in NSCLC Patients With Secondary Resistance to TKI-EGFR Status TERMINATED Phase PHASE3
NCT02174172 A Study to Assess the Safety and Tolerability of Atezolizumab in Combination With Other Immune-Modulating Therapies in Participants With Locally Advanced or Metastatic Solid Tumors Status COMPLETED Phase PHASE1
NCT02171429 A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors Status COMPLETED Phase PHASE3
NCT02168530 A Study of Oral Vismodegib for the Treatment of Idiopathic Pulmonary Fibrosis (IPF) Status WITHDRAWN Phase PHASE2
NCT02165345 Extension Study Evaluating the Safety and Efficacy of Subcutaneous Tocilizumab (RoActemra/Actemra) Administration in Systemic and Polyarticular-Course Juvenile Idiopathic Arthritis Status COMPLETED Phase PHASE1
NCT02165332 A Two-part, Single-dose, Randomized Study to Evaluate the Safety of Supra-therapeutic Doses of RO7033877 and to Investigate the Effect of RO7033877 on the QTc Interval Status COMPLETED Phase PHASE1
NCT02165293 A Single Center Study to Evaluate the Penetration of RO7033877 Into the Lung in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT02165215 A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis (UC) Participants Who Are Naive to Tumor Necrosis Factor (TNF) Inhibitors Status COMPLETED Phase PHASE3
NCT02164266 A Study to Investigate in Healthy Volunteers (Part 1) and in Patients With Type 2 Diabetes Mellitus (Part 2) the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of RO6799477 Status COMPLETED Phase PHASE1
NCT02163759 A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors Status COMPLETED Phase PHASE3
NCT02157714 Multiple Ascending Dose Study of PRX002 in Patients With Parkinson's Disease Status COMPLETED Phase PHASE1
NCT02156349 A Study Evaluating the Efficacy and the Benefit of Integrated Personalized Diabetes Management (PDM) for Diabetic Patients. Status COMPLETED Phase NA
NCT02156323 A Phase 1 Clinical Study in Healthy Volunteers to Investigate the Drug-drug Interaction Between Multiple Doses of RO7033877 and Multiple Doses of Colistin Methanesulfonate Sodium (CMS) Status COMPLETED Phase PHASE1
NCT02151370 An Observational Study of Avastin (Bevacizumab) in Patients With Ovarian Cancer Status COMPLETED Phase N/A